HBM Healthcare Investments AG
SWXA small but timely insider sale has added a new data point to HBMN's setup, arriving just as the stock heads into its October 23 half-year results with a 3.4% weekly loss still on the books. On September 24, a related legal entity connected to a non-executive board member sold 400 shares at CHF 227.03, a transaction worth roughly CHF 91,000. The trade carries a significance score…
HBMN cost to borrow surges to 1.12% — up 127% over one week, signaling tightening short availability on the Swiss healthcare investor.
Snapshot as of 26 Sept 2026
A new long-form analysis for HBMN this week — anomalies vs the company's own history, peer comparisons, news context, and the full data picture. Premium subscribers only.
Read on ORTEX →Sign up for premiumA small but timely insider sale has added a new data point to HBMN's setup, arriving just as the stock heads into its October 23 half-year results with a 3.4% weekly loss still on the books. On September 24, a related…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for HBMN — free to start on ORTEX.
